PSC833, cyclosporin A, and dexniguldipine effects on cellular calcein retention and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  1999-04-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1006/BBRC.1999.0475PMID 10198227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein.

  1998cited by this paper
• Testing the role of P-glycoprotein expression in clinical trials: applying pharmacological principles and best methods for detection together with good clinical trials methodology.

  1998cited by this paper
• Antibacterial efflux systems : Frontiers in antimicrobial resistance

  1997cited by this paper
• Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities.

  1997cited by this paper
• Antibacterial efflux systems.

  1997cited by this paper
• The role of MDR-1 in refractory lymphoma.

  1997cited by this paper
• Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein.

  1996cited by this paper
• Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay.

  1996cited by this paper
• Cellular drug efflux and reversal therapy of cancer

  1996cited by this paper
• Analysis of the interactions of SDZ PSC 833 ([3'-keto-Bmt1]-Val2]-Cyclosporine), a multidrug resistance modulator, with P-glycoprotein.

  1995cited by this paper
• Influence of dexniguldipine-HC1 on rhodamine-123 accumulation in a multidrug-resistant leukaemia cell line: comparison with other chemosensitisers.

  1994cited by this paper
• Calcein accumulation as a fluorometric functional assay of the multidrug transporter.

  1994cited by this paper
• Microfluorometric evaluation of calcein acetoxymethyl ester as a probe for P-glycoprotein-mediated resistance: effects of cyclosporin A and its nonimmunosuppressive analogue SDZ PSC 833.

  1994cited by this paper
• Reversal agent inhibition of the multidrug resistance pump in human leukemic lymphoblasts.

  1994cited by this paper
• Fluorescent cellular indicators are extruded by the multidrug resistance protein.

  1993cited by this paper
• SDZ PSC 833, A non‐immunosuppressive cyclosporine: Its potency in overcoming P‐glycoprotein‐mediated multidrug resistance of murine leukemia

  1992cited by this paper
• Kinetics of daunorubicin transport by P-glycoprotein of intact cancer cells.

  1992cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper

• Exploring the Dynamics of the ABCB1 Membrane Transporter P-glycoprotein in the Presence of ATP and Active/Non-active Compounds through Molecular Dynamics Simulations.

  2024cites this paper
• ABCC subfamily in GtoPdb v.2023.1

  2023cites this paper
• Relaciones de estructura-función en la P-glicoproteína humana (ABCB1): Perspectivas de las simulaciones de dinámica molecular

  2022cites this paper
• Structure–Function Relationships in the Human P-Glycoprotein (ABCB1): Insights from Molecular Dynamics Simulations

  2021cites this paper
• Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies

  2020cites this paper
• Nonionic surfactants increase digoxin absorption in Caco‐2 and MDCKII MDR1 cells: Impact on P‐glycoprotein inhibition, barrier function, and repeated cellular exposure

  2018influential citation
• Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance

  2016cites this paper
• Reversing multidrug resistance by intracellular delivery of Pluronic® P85 unimers.

  2013cites this paper
• P-glycoprotein (P-gp/MDR1)/ABCB1

  2013cites this paper
• Dihydropyridines and Multidrug Resistance: Previous Attempts, Present State, and Future Trends

  2010cites this paper
• Predicting drug-drug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein.

  2010cites this paper
• Naturally-occurring shikonin analogues--a class of necroptotic inducers that circumvent cancer drug resistance.

  2009cites this paper
• (99m)Tc-MIBI imaging for prediction of therapeutic effects of second-generation MDR1 inhibitors in malignant brain tumors.

  2007cites this paper
• 99mTc‐MIBI imaging for prediction of therapeutic effects of second‐generation MDR1 inhibitors in malignant brain tumors

  2007cites this paper
• In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.

  2005cites this paper
• NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS

  2005cites this paper
• Targeting Molecular Signals in Chk1 Pathways as a New Approach for Overcoming Drug Resistance

  2004cites this paper
• Relation between the ability of some compounds to modulate the MRP1-mediated efflux of glutathione and to inhibit the MRPl-mediated efflux of daunorubicin.

  2004cites this paper
• Characterisation of COAS2, a candidate proto-oncogene amplified and over-expressed in human mesenchymal tumours

  2004cites this paper
• New multidrug resistance reversal agents.

  2003cites this paper
• Energy dependent transport of xenobiotics and its relevance to multidrug resistance.

  2003cites this paper
• The multidrug resistance mechanisms and their interactions with the radiopharmaceutical probes used for an in vivo detection.

  2002cites this paper
• Transport of new non-cross-resistant antitumor compounds of the benzoperimidine family in multidrug resistant cells.

  2001cites this paper
• Specific MDR1 P-Glycoprotein Blockade Inhibits Human Alloimmune T Cell Activation In Vitro1

  2001cites this paper
• Structure-activity relationships and optimisation of the selective MDR modulator 2-(3,4-dimethoxyphenyl)-5-(9-fluorenylamino)-2-(methylethyl) pentanenitrile and its N-methyl derivative.

  2001cites this paper
• Screening and discovery of novel MDR modifiers from naturally occurring bisbenzylisoquinoline alkaloids.

  2001cites this paper
• This information is current as Activation In Vitro Inhibits Human Alloimmune T Cell Specific MDR 1 P-Glycoprotein Blockade Briscoe

  2001cites this paper
• Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating

  2000influential citation
• The role of protein kinase C in MDRI gene transcription in multidrug resistant tumours

  2000cites this paper
• Up-regulation of Multidrug Resistance P-glycoprotein via Nuclear Factor-κB Activation Protects Kidney Proximal Tubule Cells from Cadmium- and Reactive Oxygen Species-induced Apoptosis*

  2000cites this paper
• Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.

  2000cites this paper